Literature DB >> 20965747

Effect of storage conditions on the stability of recombinant human MCP-1/CCL2.

Krisada Leemasawatdigul1, Heather Gappa-Fahlenkamp.   

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is commercially available in a form of recombinant protein. This makes it more convenient to study the functions of MCP-1 and its involvement in many cell functions. However, when using MCP-1 in experimental studies, if the analysis is not performed immediately, the stability of recombinant MCP-1 may become an issue. In this study, the stability of recombinant MCP-1 at different concentrations and storage conditions was investigated. Results show that no significant loss of MCP-1 is observed when MCP-1 solutions were stored at non-freezing condition (4 °C) for seven days. However, for storage at freezing conditions (-20 °C or -81 °C), it appears that the first freeze-thaw cycle may contribute to some loss of MCP-1 in the solutions, and such loss may be concentration and time dependent. The effect of multiple freeze-thaw cycles for storage at freezing conditions was also examined. Data reveal that the second freeze-thaw cycle causes approximately 50% loss of MCP-1 in the solutions. This finding confirms that multiple freeze-thaw cycles should be avoided. The findings of this study provide an outline of how storage can affect the stability of recombinant proteins and should be taken into account during the evaluation of the concentration of recombinant proteins.
Copyright © 2010 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965747      PMCID: PMC3025303          DOI: 10.1016/j.biologicals.2010.09.003

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  15 in total

Review 1.  Structure, function, and inhibition of chemokines.

Authors:  Elias J Fernandez; Elias Lolis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture.

Authors:  A J Valente; D T Graves; C E Vialle-Valentin; R Delgado; C J Schwartz
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

Review 4.  Chemokines and atherosclerosis.

Authors:  T J Reape; P H Groot
Journal:  Atherosclerosis       Date:  1999-12       Impact factor: 5.162

5.  Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop.

Authors:  T Yamamoto; B Eckes; C Mauch; K Hartmann; T Krieg
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

Review 6.  Monocyte chemoattractant protein-1 (MCP-1): an overview.

Authors:  Satish L Deshmane; Sergey Kremlev; Shohreh Amini; Bassel E Sawaya
Journal:  J Interferon Cytokine Res       Date:  2009-06       Impact factor: 2.607

7.  Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

Authors:  Karin Jöhrer; Katrin Janke; Jens Krugmann; Michael Fiegl; Richard Greil
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

8.  Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration.

Authors:  Lynne A Hardy; Trevor A Booth; Elaine K Lau; Tracy M Handel; Simi Ali; John A Kirby
Journal:  Lab Invest       Date:  2004-01       Impact factor: 5.662

9.  Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.

Authors:  K Matsushima; C G Larsen; G C DuBois; J J Oppenheim
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants.

Authors:  T Yoshimura; E A Robinson; S Tanaka; E Appella; J Kuratsu; E J Leonard
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  7 in total

1.  A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration.

Authors:  Neda Ghousifam; Hamid Mortazavian; Rudra Bhowmick; Yolanda Vasquez; Frank D Blum; Heather Gappa-Fahlenkamp
Journal:  Int J Biol Macromol       Date:  2016-12-29       Impact factor: 6.953

2.  Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.

Authors:  A Lianne Messchendorp; Esther Meijer; Folkert W Visser; Gerwin E Engels; Peter Kappert; Monique Losekoot; Dorien J M Peters; Ron T Gansevoort
Journal:  Am J Nephrol       Date:  2019-10-10       Impact factor: 3.754

3.  Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial.

Authors:  Bart J Kramers; Iris W Koorevaar; Maatje D A van Gastel; Harry van Goor; Kenneth R Hallows; Hiddo L Heerspink; Hui Li; Wouter N Leonhard; Dorien J M Peters; Jiedong Qiu; Daan J Touw; Ron T Gansevoort; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-21       Impact factor: 8.237

Review 4.  Regulation of macrophage biology by lithium: a new look at an old drug.

Authors:  Pongali B Raghavendra; Eunhee Lee; Narayanan Parameswaran
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-27       Impact factor: 4.147

5.  Stability of pro- and anti-inflammatory immune biomarkers for human cohort studies.

Authors:  C Graham; R Chooniedass; W P Stefura; L Lotoski; P Lopez; A D Befus; A B Becker; K T HayGlass
Journal:  J Transl Med       Date:  2017-03-02       Impact factor: 5.531

6.  Lithium ameliorates tubule-interstitial injury through activation of the mTORC2/protein kinase B pathway.

Authors:  Douglas E Teixeira; Diogo B Peruchetti; Leandro S Silva; Rodrigo P Silva-Aguiar; Morgana B Oquendo; João Luiz Silva-Filho; Christina M Takiya; José Henrique Leal-Cardoso; Ana Acacia S Pinheiro; Celso Caruso-Neves
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

7.  Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.

Authors:  Nikolaos I Kanellakis; John M Wrightson; Rob Hallifax; Eihab O Bedawi; Rachel Mercer; Maged Hassan; Rachelle Asciak; Emma Hedley; Melissa Dobson; Tao Dong; Ioannis Psallidas; Najib M Rahman
Journal:  BMJ Open Respir Res       Date:  2019-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.